|
Outreach to address noncompliance issues may enhance mammography screening rates
(Science Letter Via Thomson Dialog NewsEdge)
Targeted outreach to address non-compliance issues may enhance mammography screening rates.
According to scientists at the Institut Gustave-Roussy, "Evidence of the benefits of screening for breast cancer using mammography after the age of 50 is considered sufficient. Information on the determinants of compliance to the recommendations on mammography is needed to identify women to which public health messages should be specifically addressed and also to interpret results from epidemiological data in which some breast cancer cases are detected through screening programs and others are not."
"The general characteristics and dietary data of French women participating in the E3N cohort study were analyzed," explained C. Flamant and colleagues. "Odds ratios of the frequency of noncompliance to recommendations on breast cancer screening were computed in women over and under the age of 50."
The researchers found, "Noncompliant women over 50 (i.e. never-attenders) had a poorer access to physicians and poorer health with regard to specific risk factors even after adjustment for age and educational level. Women who were used to referring to gynecologists early in life were better attenders later on. Logically, women under 50 who were overscreened, as compared to public health recommendations, had the opposite characteristics."
"Public health recommendations should be designed specifically according to targeted subgroups of women," concluded the authors. "Determinants of attendance for screening should be kept in mind in the interpretation of epidemiological studies in which some cases may be overscreened and others not."
Flamant and colleagues published the results of their research in European Journal of Cancer Prevention (Determinants of noncompliance to recommendations on breast cancer screening among women participating in the French E3N cohort study. Eur J Cancer Prev, 2006;15(1):27-33).
For additional information, contact C. Flamant, Paediatric Intensive Care Unit, Trousseau Childrens Hospital, 26 avenue du Docteur Netter, 75012 Paris, France; E-mail: cyril.flamant@trs.ap-hop-paris.fr.
The publisher of the European Journal of Cancer Prevention can be contacted at: Lippincott, Williams, & Wilkins, 530 Walnut Street, Philadelphia, PA 19106-3261, USA.
Keywords: Villejuif, France, Breast Cancer, Breast Cancer Screening, Breast Carcinoma, Breast Carcinoma Screening, Breast Cancer Diagnosis, Mammography, Women's Health.
This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via NewsRx.com.
[ Back To HD Voice's Homepage ]
|
